First Edition: June 27, 2023
Today's early morning highlights from the major news organizations.
The independent source for health policy research, polling, and news.
7,801-7,820 of 112,997 results
Today's early morning highlights from the major news organizations.
Opinion writers tackle these public health issues.
Editorial writers discuss the effects of overturning Roe, one year later.
A handful of new cases over recent weeks have hit Colorado, and now health officials are launching a new vaccination campaign. Meanwhile, in Missouri, hospitals are reported to be housing children in foster care for weeks because there was nowhere else for them to live.
A new study from University of California, Irvine, shows that skin moles with hair contain molecules that promote hair growth. Among other news items, Black veterans are denied VA health benefits more often than white peers; a focus on a statin alternative for tackling cholesterol; and more.
Four Chinese chemical factories who make precursor components for the painkiller illegally trafficked the chemicals, the Justice Department alleges. Separately, Reuters reports the cocaine market is booming worldwide, and meth trafficking is reaching new markets.
NBC News reports the nation's medical schools aren't preparing doctors to properly care for the LGBTQ+ population. The Houston Chronicle highlights how one former health leader was part of a group of conservative doctors using questionable science to tackle abortions and trans health care.
Almost 1 in 3 registered nurses surveyed say they're likely to seek a different job, raising the prospect of a mass exodus from the industry. Northwell Health, Tenet Healthcare, Clover Health, and more are also in health industry news.
The once-daily pill from Pfizer, called Litfulo, helped about a quarter of patients regain 80% or more of hair coverage on their scalp after six months of treatment. Health experts called it a "game changer" for affected teens and their self esteem.
As the CDC tracks several new covid variants, Utah labs have reported the most EU.1.1 infections of any state, with nearly 100 cases sequenced. By contrast, Nevada and Colorado have reported cases in only the single digits. The strain is a distant descendant of the XBB.1.5 variant seen in Europe earlier this year.
After Roe v. Wade was overturned a year ago, abortion rights groups saw a huge influx of monetary donations from supporters, but that trend has dropped off over the last year. Abortion access news is reported from the states, as well.
The order instructs federal agencies to enforce the ACA requirement that all private insurers cover all FDA-approved contraceptives and to consider new measures to broaden access to birth control. Biden signed it at one of a series of administration events marking the one-year anniversary of the Supreme Court's decision that reversed abortion rights.
Today's early morning highlights from the major news organizations.
Each week, KFF Health News finds longer stories for you to enjoy. This week's selections include stories on the morgue scandal, the health benefits of fresh air, cancer, psychedelics, and more.
The new data is from an annual ranking released Thursday by The Commonwealth Fund. Meanwhile, Iowa Public Radio reports that though the federal government offered states the option to expand Medicaid postpartum coverage to a year, some are turning it down.
Stat reports on the potential of a program from CMS called Transitional Coverage for Emerging Technologies, which would apply to medical products deemed “breakthrough devices” by the FDA. Also in the news: an effort to change the way Medicare pays physicians.
The Washington Post covers efforts by the Biden administration to impact the influx of illegal opioids into the U.S. Meanwhile, Axios reports that preventable deaths, including by suicide and drug overdose, increased during the pandemic. Also: AP examines Xylazine's role in the opioid crisis.
In what NPR calls an "eagerly anticipated decision," the FDA approved Thursday a treatment called Elevidys from Sarepta Therapeutics to treat Duchenne muscular dystrophy by targeting the genetic defect behind it. The treatment costs $3.2 million. Also in the news: the high cost of drugs.
The drugmaker's newest covid shots target the variant that currently dominates new covid infections in the U.S. — XBB.1.5. The FDA recently indicated that new shots for the fall should be aimed at these variants. Also in the news, how long covid can affect mental health.
The company announced Thursday it will pay at least this sum to settle lawsuits over contamination of U.S. drinking water systems with potentially harmful "forever chemicals," AP reports. Also in the news, "cancer alley" in Louisiana, Minneapolis' poor air quality, and more.
© 2026 KFF